{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:04:38Z","timestamp":1793786678203,"version":"4.6.1"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\/0.0\/15_003\/0000419"],"award-info":[{"award-number":["\/0.0\/15_003\/0000419"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0"],"award-info":[{"award-number":["CZ.02.1.01\/0.0"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jare.2023.01.006","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T21:15:02Z","timestamp":1673644502000},"page":"105-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?"],"prefix":"10.1016","volume":"54","author":[{"given":"Francisco Javier","family":"Rodriguez-Jimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ure\u00f1a-Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Jendelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slaven","family":"Erceg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2023.01.006_b0005","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1468-1331.2010.03040.x","article-title":"EFNS guidelines for the diagnosis and management of Alzheimer's disease","volume":"17","author":"Hort","year":"2010","journal-title":"European journal of neurology : the official journal of the European Federation of Neurological Societies"},{"key":"10.1016\/j.jare.2023.01.006_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0015","doi-asserted-by":"crossref","unstructured":"S.J. Crutch, J.M. Schott, G.D. Rabinovici, M. Murray, J.S. Snowden, W.M. van der Flier, B.C. Dickerson, R. Vandenberghe, S. Ahmed, T.H. Bak, B.F. Boeve, C. Butler, S.F. Cappa, M. Ceccaldi, L.C. de Souza, B. Dubois, O. Felician, D. Galasko, J. Graff-Radford, N.R. Graff-Radford, P.R. Hof, P. Krolak-Salmon, M. Lehmann, E. Magnin, M.F. Mendez, P.J. Nestor, C.U. Onyike, V.S. Pelak, Y. Pijnenburg, S. Primativo, M.N. Rossor, N.S. Ryan, P. Scheltens, T.J. Shakespeare, A. Suarez Gonzalez, D.F. Tang-Wai, K.X.X. Yong, M. Carrillo, N.C. Fox, I.A.A.s.D. Alzheimer's Association, and A. Associated Syndromes Professional Interest, Consensus classification of posterior cortical atrophy. Alzheimers Dement 13 (2017) 870-884.","DOI":"10.1016\/j.jalz.2017.01.014"},{"key":"10.1016\/j.jare.2023.01.006_b0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jare.2023.01.006_b0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0030","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1074\/jbc.M808759200","article-title":"Propagation of tau misfolding from the outside to the inside of a cell","volume":"284","author":"Frost","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2023.01.006_b0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0045","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tins.2019.03.003","article-title":"A Unifying Hypothesis for Alzheimer's Disease: From Plaques to Neurodegeneration","volume":"42","author":"Edwards","year":"2019","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0055","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/NEN.0b013e3181772794","article-title":"Neuronal hypertrophy in asymptomatic Alzheimer disease","volume":"67","author":"Iacono","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0060","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer's disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.jare.2023.01.006_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jare.2023.01.006_b0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer's disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jare.2023.01.006_b0080","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and Abeta: implications for Alzheimer's disease pathology and therapeutics","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jare.2023.01.006_b0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41573-020-0065-9","article-title":"Leveraging preclinical models for the development of Alzheimer disease therapeutics","volume":"19","author":"Scearce-Levie","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jare.2023.01.006_b0090","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jare.2023.01.006_b0095","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrneurol.2009.175","article-title":"Changing perspectives regarding late-life dementia","volume":"5","author":"Fotuhi","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jare.2023.01.006_b0105","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and 'wingmen'","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jare.2023.01.006_b0115","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archneurol.2011.70","article-title":"Amyloid-dependent and amyloid-independent stages of Alzheimer disease","volume":"68","author":"Hyman","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jalz.2016.03.018","article-title":"Tau: From research to clinical development","volume":"12","author":"Holtzman","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jare.2023.01.006_b0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005072-199005000-00003","article-title":"Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes","volume":"49","author":"Braak","year":"1990","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","article-title":"Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease","volume":"69","author":"Nagy","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.jare.2023.01.006_b0135","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nn.2433","article-title":"Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses","volume":"12","author":"Abramov","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.22313","article-title":"Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory","volume":"69","author":"Puzzo","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0145","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1523\/JNEUROSCI.1879-05.2005","article-title":"Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy","volume":"25","author":"Spires","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00401-010-0787-6","article-title":"In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks","volume":"121","author":"Burgold","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jare.2023.01.006_b0155","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1523\/JNEUROSCI.0227-12.2012","article-title":"Distinct dendritic spine and nuclear phases of calcineurin activation after exposure to amyloid-beta revealed by a novel fluorescence resonance energy transfer assay","volume":"32","author":"Wu","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0160","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1471-4159.2010.07058.x","article-title":"N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-beta peptide oligomers","volume":"115","author":"Decker","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.jare.2023.01.006_b0165","doi-asserted-by":"crossref","first-page":"e1791","DOI":"10.1038\/cddis.2015.160","article-title":"Calcium flux-independent NMDA receptor activity is required for Abeta oligomer-induced synaptic loss","volume":"6","author":"Birnbaum","year":"2015","journal-title":"Cell Death Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jare.2023.01.006_b0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jnc.13632","article-title":"The amyloid cascade hypothesis: are we poised for success or failure?","volume":"139","author":"Karran","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.jare.2023.01.006_b0175","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/jnen\/nly059","article-title":"beta-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals","volume":"77","author":"Wu","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0180","first-page":"67","article-title":"Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease","volume":"23","author":"Howlett","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jare.2023.01.006_b0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"and Contributors, NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jare.2023.01.006_b0190","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/emboj.2013.207","article-title":"Amyloid-beta oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin","volume":"32","author":"Zempel","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.jare.2023.01.006_b0195","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","article-title":"Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines","volume":"30","author":"Zempel","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0200","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.nbd.2010.11.014","article-title":"Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice","volume":"41","author":"Rozkalne","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jare.2023.01.006_b0205","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1523\/JNEUROSCI.4456-09.2010","article-title":"Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation","volume":"30","author":"Wu","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0210","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric abeta, and frank neuronal loss","volume":"33","author":"Cohen","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/alzrt214","article-title":"Propagation of tau pathology in Alzheimer's disease: identification of novel therapeutic targets","volume":"5","author":"Pooler","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jare.2023.01.006_b0220","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1038\/s41598-019-43076-y","article-title":"Synapse loss and progress of Alzheimer's disease -A network model","volume":"9","author":"Kashyap","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0225","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/brain\/awaa395","article-title":"Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jare.2023.01.006_b0230","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1073\/pnas.1219256110","article-title":"In vivo single branch axotomy induces GAP-43-dependent sprouting and synaptic remodeling in cerebellar cortex","volume":"110","author":"Allegra Mascaro","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2023.01.006_b0235","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4161\/cib.3.4.11763","article-title":"Neurogranin and synaptic plasticity balance","volume":"3","author":"Zhong","year":"2010","journal-title":"Commun Integr Biol"},{"key":"10.1016\/j.jare.2023.01.006_b0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jare.2023.01.006_b0245","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biopsych.2012.11.028","article-title":"Resting state functional connectivity in preclinical Alzheimer's disease","volume":"74","author":"Sheline","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jare.2023.01.006_b0250","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/brain\/awv007","article-title":"Amyloid-beta deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression","volume":"138","author":"Huijbers","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jare.2023.01.006_b0255","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jalz.2017.02.011","article-title":"Tau and amyloid beta proteins distinctively associate to functional network changes in the aging brain","volume":"13","author":"Sepulcre","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jare.2023.01.006_b0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tins.2008.11.007","article-title":"Tau pathophysiology in neurodegeneration: a tangled issue","volume":"32","author":"Spires-Jones","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0265","first-page":"5380346","article-title":"Clinical Trials in Alzheimer's Disease: A Hurdle in the Path of Remedy","volume":"2020","author":"Oxford","year":"2020","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.jare.2023.01.006_b0270","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2023.01.006_b0275","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000116984","article-title":"Staging of Alzheimer-related cortical destruction","volume":"33","author":"Braak","year":"1993","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0280","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1073\/pnas.98.2.676","article-title":"A default mode of brain function","volume":"98","author":"Raichle","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2023.01.006_b0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0290","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/WNL.50.6.1563","article-title":"Preclinical prediction of Alzheimer's disease using SPECT","volume":"50","author":"Johnson","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jare.2023.01.006_b0295","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02988596","article-title":"Cerebral blood flow and metabolic abnormalities in Alzheimer's disease","volume":"15","author":"Matsuda","year":"2001","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jare.2023.01.006_b0300","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/brain\/awf185","article-title":"Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease","volume":"125","author":"Bradley","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jare.2023.01.006_b0305","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.0308627101","article-title":"Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI","volume":"101","author":"Greicius","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2023.01.006_b0310","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The Cellular Phase of Alzheimer's Disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jare.2023.01.006_b0315","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41593-018-0080-x","article-title":"Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer's disease","volume":"21","author":"Styr","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0320","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm.4330","article-title":"Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease","volume":"23","author":"Lam","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2023.01.006_b0325","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0330","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s13311-017-0541-z","article-title":"Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease","volume":"14","author":"Haberman","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jare.2023.01.006_b0335","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006338","article-title":"Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction","volume":"2","author":"Mucke","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jare.2023.01.006_b0340","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(00)81109-5","article-title":"Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles","volume":"24","author":"Mesulam","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/REVNEURO.2009.20.1.1","article-title":"Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid","volume":"20","author":"Nimmrich","year":"2009","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0350","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jare.2023.01.006_b0355","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0360","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0365","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1531-8249(20010201)49:2<202::AID-ANA40>3.0.CO;2-3","article-title":"Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment","volume":"49","author":"Kordower","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-015-0110-9","article-title":"Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model","volume":"7","author":"Nygaard","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jare.2023.01.006_b0375","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jare.2023.01.006_b0380","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ana.22105","article-title":"Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease","volume":"68","author":"Quiroz","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0385","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuron.2017.11.028","article-title":"Alzheimer's Disease: From Firing Instability to Homeostasis Network Collapse","volume":"97","author":"Frere","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0390","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1474-4422(10)70277-5","article-title":"Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease","volume":"10","author":"Kapogiannis","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0395","doi-asserted-by":"crossref","first-page":"e1592","DOI":"10.1212\/WNL.0000000000009249","article-title":"In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease","volume":"94","author":"Terada","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jare.2023.01.006_b0400","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12035-021-02612-6","article-title":"Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease","volume":"59","author":"Dhapola","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jare.2023.01.006_b0405","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0410","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/acsbiomaterials.0c01583","article-title":"Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease","volume":"7","author":"Yin","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.jare.2023.01.006_b0415","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jare.2023.01.006_b0420","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jare.2023.01.006_b0425","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1242\/dev.036624","article-title":"Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells","volume":"136","author":"Li","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.jare.2023.01.006_b0430","doi-asserted-by":"crossref","first-page":"e2122","DOI":"10.1371\/journal.pone.0002122","article-title":"Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions","volume":"3","author":"Erceg","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2023.01.006_b0435","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/nprot.2013.106","article-title":"Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells","volume":"8","author":"Liu","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jare.2023.01.006_b0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-9-3","article-title":"Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death","volume":"9","author":"Duan","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jare.2023.01.006_b0445","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2023.01.006_b0450","doi-asserted-by":"crossref","unstructured":"B. Foveau, A.S. Correia, S.S. Hebert, S. Rainone, O. Potvin, M.J. Kergoat, S. Belleville, S. Duchesne, A.C. LeBlanc, and C.-Q.C.f.t.e.i.o.A.s.d.-Q. the, Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease. Journal of Alzheimer's disease : JAD 67 (2019) 893-910.","DOI":"10.3233\/JAD-180833"},{"key":"10.1016\/j.jare.2023.01.006_b0455","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-017-0317-z","article-title":"Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation","volume":"9","author":"Ochalek","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jare.2023.01.006_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101878","article-title":"Neural oscillations and brain stimulation in Alzheimer's disease","volume":"194","author":"Jafari","year":"2020","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jare.2023.01.006_b0465","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1039\/D0CS00107D","article-title":"Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers","volume":"49","author":"Kim","year":"2020","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.jare.2023.01.006_b0470","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-neuro-070815-014015","article-title":"Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics","volume":"39","author":"Sala Frigerio","year":"2016","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0475","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer's disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jare.2023.01.006_b0480","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1523\/JNEUROSCI.4707-08.2009","article-title":"Uniquely hominid features of adult human astrocytes","volume":"29","author":"Oberheim","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0485","unstructured":"[The role of Italian cardiology in the Italian Group for the Study of Streptokinase in Myocardial Infarct. Distribution, structural and organizational characteristics of coronary intensive care units]. G Ital Cardiol 17 (1987) 14-9."},{"key":"10.1016\/j.jare.2023.01.006_b0490","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tins.2013.12.001","article-title":"The human side of microglia","volume":"37","author":"Smith","year":"2014","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0495","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0500","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of Alzheimer disease: back to the future","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0505","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","article-title":"Modeling familial Alzheimer's disease with induced pluripotent stem cells","volume":"20","author":"Yagi","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jare.2023.01.006_b0510","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2016.12.060","article-title":"Increased susceptibility to Abeta toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells","volume":"639","author":"Armijo","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jare.2023.01.006_b0515","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.celrep.2015.03.068","article-title":"APP metabolism regulates tau proteostasis in human cerebral cortex neurons","volume":"11","author":"Moore","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0520","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.18632\/oncotarget.13776","article-title":"Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2023.01.006_b0525","doi-asserted-by":"crossref","first-page":"e84547","DOI":"10.1371\/journal.pone.0084547","article-title":"Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors","volume":"9","author":"Sproul","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2023.01.006_b0530","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jare.2023.01.006_b0535","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1177\/0963689718775406","article-title":"Induced Pluripotent Stem Cells: A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery","volume":"27","author":"Chang","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jare.2023.01.006_b0540","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1007\/s12035-018-1336-x","article-title":"Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation","volume":"56","author":"Chang","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jare.2023.01.006_b0545","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","article-title":"Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness","volume":"12","author":"Kondo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jare.2023.01.006_b0550","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.stemcr.2017.10.015","article-title":"Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability","volume":"9","author":"Muratore","year":"2017","journal-title":"Stem Cell Rep"},{"issue":"Suppl 9","key":"10.1016\/j.jare.2023.01.006_b0555","first-page":"7","article-title":"Neuropathologic changes in Alzheimer's disease","volume":"64","author":"Wenk","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jare.2023.01.006_b0560","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1523\/JNEUROSCI.2735-15.2016","article-title":"Single-Cell Detection of Secreted Abeta and sAPPalpha from Human IPSC-Derived Neurons and Astrocytes","volume":"36","author":"Liao","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0565","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2013.09.005","article-title":"Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: a model system to study neurotoxicity in Alzheimer's disease","volume":"62","author":"Vazin","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jare.2023.01.006_b0570","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.freeradbiomed.2017.08.028","article-title":"Exosomal biomarkers in Down syndrome and Alzheimer's disease","volume":"114","author":"Hamlett","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2023.01.006_b0575","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3233\/JAD-160945","article-title":"Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro","volume":"56","author":"Dashinimaev","year":"2017","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"10.1016\/j.jare.2023.01.006_b0580","doi-asserted-by":"crossref","first-page":"124ra29","DOI":"10.1126\/scitranslmed.3003771","article-title":"A human stem cell model of early Alzheimer's disease pathology in Down syndrome","volume":"4","author":"Shi","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jare.2023.01.006_b0585","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","article-title":"Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease","volume":"64","author":"Graff-Radford","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0590","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.stemcr.2018.05.004","article-title":"The Impact of APP on Alzheimer-like Pathogenesis and Gene Expression in Down Syndrome iPSC-Derived Neurons","volume":"11","author":"Ovchinnikov","year":"2018","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0595","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.celrep.2013.10.018","article-title":"The presenilin-1 DeltaE9 mutation results in reduced gamma-secretase activity, but not total loss of PS1 function, in isogenic human stem cells","volume":"5","author":"Woodruff","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0600","doi-asserted-by":"crossref","unstructured":"P. Martin-Maestro, R. Gargini, A.S. A, E. Garcia, L.C. Anton, S. Noggle, O. Arancio, J. Avila, and V. Garcia-Escudero, Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer's Disease-Associated Presenilin 1 Mutation. Front Mol Neurosci 10 (2017) 291.","DOI":"10.3389\/fnmol.2017.00291"},{"key":"10.1016\/j.jare.2023.01.006_b0605","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JAD-170830","article-title":"Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease","volume":"62","author":"Wezyk","year":"2018","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"10.1016\/j.jare.2023.01.006_b0610","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/jnr.22387","article-title":"Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice","volume":"88","author":"Demars","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jare.2023.01.006_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108615","article-title":"Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis","volume":"34","author":"Arber","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0620","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1038\/s41380-020-0776-7","article-title":"NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models","volume":"26","author":"Ghatak","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jare.2023.01.006_b0625","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50333","article-title":"Mechanisms of hyperexcitability in Alzheimer's disease hiPSC-derived neurons and cerebral organoids vs isogenic controls","volume":"8","author":"Ghatak","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jare.2023.01.006_b0630","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.neuron.2018.05.019","article-title":"Theta and Alpha Oscillations Are Traveling Waves in the Human Neocortex","volume":"98","author":"Zhang","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0635","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-131322","article-title":"Abnormal amplitude of low-frequency fluctuations of intrinsic brain activity in Alzheimer's disease","volume":"40","author":"Liu","year":"2014","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"10.1016\/j.jare.2023.01.006_b0640","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0645","doi-asserted-by":"crossref","unstructured":"J.C. Lambert, C.A. Ibrahim-Verbaas, D. Harold, A.C. Naj, R. Sims, C. Bellenguez, A.L. DeStafano, J.C. Bis, G.W. Beecham, B. Grenier-Boley, G. Russo, T.A. Thorton-Wells, N. Jones, A.V. Smith, V. Chouraki, C. Thomas, M.A. Ikram, D. Zelenika, B.N. Vardarajan, Y. Kamatani, C.F. Lin, A. Gerrish, H. Schmidt, B. Kunkle, M.L. Dunstan, A. Ruiz, M.T. Bihoreau, S.H. Choi, C. Reitz, F. Pasquier, C. Cruchaga, D. Craig, N. Amin, C. Berr, O.L. Lopez, P.L. De Jager, V. Deramecourt, J.A. Johnston, D. Evans, S. Lovestone, L. Letenneur, F.J. Moron, D.C. Rubinsztein, G. Eiriksdottir, K. Sleegers, A.M. Goate, N. Fievet, M.W. Huentelman, M. Gill, K. Brown, M.I. Kamboh, L. Keller, P. Barberger-Gateau, B. McGuiness, E.B. Larson, R. Green, A.J. Myers, C. Dufouil, S. Todd, D. Wallon, S. Love, E. Rogaeva, J. Gallacher, P. St George-Hyslop, J. Clarimon, A. Lleo, A. Bayer, D.W. Tsuang, L. Yu, M. Tsolaki, P. Bossu, G. Spalletta, P. Proitsi, J. Collinge, S. Sorbi, F. Sanchez-Garcia, N.C. Fox, J. Hardy, M.C. Deniz Naranjo, P. Bosco, R. Clarke, C. Brayne, D. Galimberti, M. Mancuso, F. Matthews, I. European Alzheimer's Disease, Genetic, D. Environmental Risk in Alzheimer's, C. Alzheimer's Disease Genetic, H. Cohorts for, E. Aging Research in Genomic, S. Moebus, P. Mecocci, M. Del Zompo, W. Maier, H. Hampel, A. Pilotto, M. Bullido, F. Panza, P. Caffarra, et al., Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature genetics 45 (2013) 1452-8.","DOI":"10.1038\/ng.2802"},{"key":"10.1016\/j.jare.2023.01.006_b0650","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0655","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2023.01.006_b0660","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.celrep.2019.01.023","article-title":"REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer's Disease","volume":"26","author":"Meyer","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0665","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-021-02117-y","article-title":"Pharmacological ablation of astrocytes reduces Abeta degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease","volume":"18","author":"Davis","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jare.2023.01.006_b0670","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrn3484","article-title":"Emerging roles of astrocytes in neural circuit development","volume":"14","author":"Clarke","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0675","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuron.2008.10.013","article-title":"The mystery and magic of glia: a perspective on their roles in health and disease","volume":"60","author":"Barres","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0680","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tem.2013.10.003","article-title":"What are lipoproteins doing in the brain?","volume":"25","author":"Wang","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jare.2023.01.006_b0685","first-page":"1052","article-title":"Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain","volume":"146","author":"Nishimura","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2023.01.006_b0690","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/brain\/awab478","article-title":"APOE4 derived from astrocytes leads to blood-brain barrier impairment","volume":"145","author":"Jackson","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jare.2023.01.006_b0695","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1148\/radiol.2017164043","article-title":"Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease","volume":"282","author":"van de Haar","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jare.2023.01.006_b0700","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(03)02361-8","article-title":"Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains","volume":"971","author":"Nagele","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.jare.2023.01.006_b0705","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0014-4886(91)90115-S","article-title":"Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation","volume":"112","author":"Vijayan","year":"1991","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0710","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/glia.20967","article-title":"Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease","volume":"58","author":"Olabarria","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.jare.2023.01.006_b0715","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-associated astrocytes in Alzheimer's disease and aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0720","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1471-4159.1996.67010277.x","article-title":"Amyloid beta peptide (25\u201335) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures","volume":"67","author":"Harris","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.jare.2023.01.006_b0725","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.410400512","article-title":"Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease","volume":"40","author":"Masliah","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0730","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nbt.1877","article-title":"Specification of transplantable astroglial subtypes from human pluripotent stem cells","volume":"29","author":"Krencik","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2023.01.006_b0735","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1038\/cddis.2017.89","article-title":"Aberrant iPSC-derived human astrocytes in Alzheimer's disease","volume":"8","author":"Jones","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2023.01.006_b0740","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/stem.1334","article-title":"Efficient generation of astrocytes from human pluripotent stem cells in defined conditions","volume":"31","author":"Shaltouki","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.jare.2023.01.006_b0745","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","article-title":"PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease","volume":"9","author":"Oksanen","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0750","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","article-title":"APOE epsilon4\/epsilon4 diminishes neurotrophic function of human iPSC-derived astrocytes","volume":"26","author":"Zhao","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jare.2023.01.006_b0755","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1074\/jbc.RA117.000441","article-title":"Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-beta clearance in human astrocytes","volume":"293","author":"Fong","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2023.01.006_b0760","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-981-13-9913-8_12","article-title":"Oligodendroglial Cells in Alzheimer's Disease","volume":"1175","author":"Butt","year":"2019","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.jare.2023.01.006_b0765","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2353\/ajpath.2010.100087","article-title":"Early oligodendrocyte\/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target","volume":"177","author":"Desai","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2023.01.006_b0770","doi-asserted-by":"crossref","first-page":"E2243","DOI":"10.1073\/pnas.1614412114","article-title":"Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors","volume":"114","author":"Ehrlich","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2023.01.006_b0775","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/stem.489","article-title":"Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection","volume":"28","author":"Erceg","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.jare.2023.01.006_b0780","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/nprot.2009.186","article-title":"Differentiation of human oligodendrocytes from pluripotent stem cells","volume":"4","author":"Hu","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jare.2023.01.006_b0785","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jare.2023.01.006_b0790","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jare.2023.01.006_b0795","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"Alzheimer Genetic Analysis, TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2023.01.006_b0800","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","article-title":"TREM2, Microglia, and Neurodegenerative Diseases","volume":"23","author":"Yeh","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jare.2023.01.006_b0805","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0810","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","article-title":"Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models","volume":"97","author":"Lee","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0815","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/cercor\/bhx046","article-title":"Neuronal and Peripheral Pentraxins Modify Glutamate Release and may Interact in Blood-Brain Barrier Failure","volume":"27","author":"Cummings","year":"2017","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.jare.2023.01.006_b0820","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2017.05.037","article-title":"TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss","volume":"95","author":"Paolicelli","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0825","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-2094-6-35","article-title":"Expression of complement system components during aging and amyloid deposition in APP transgenic mice","volume":"6","author":"Reichwald","year":"2009","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jare.2023.01.006_b0830","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2023.01.006_b0835","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/brain\/awv081","article-title":"Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain","volume":"138","author":"Maphis","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jare.2023.01.006_b0840","doi-asserted-by":"crossref","first-page":"e60921","DOI":"10.1371\/journal.pone.0060921","article-title":"Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology","volume":"8","author":"Krabbe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2023.01.006_b0845","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn.2432","article-title":"Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia","volume":"12","author":"Grathwohl","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0850","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jare.2023.01.006_b0855","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/JAD-180722","article-title":"Pathological Changes in Alzheimer's Disease Analyzed Using Induced Pluripotent Stem Cell-Derived Human Microglia-Like Cells","volume":"67","author":"Xu","year":"2019","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"10.1016\/j.jare.2023.01.006_b0860","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13311-014-0316-8","article-title":"The evolving biology of microglia in Alzheimer's disease","volume":"12","author":"Malm","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jare.2023.01.006_b0865","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jare.2023.01.006_b0870","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1073\/pnas.1520760112","article-title":"Human cerebral organoids recapitulate gene expression programs of fetal neocortex development","volume":"112","author":"Camp","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2023.01.006_b0875","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.aaf6116","article-title":"Zika virus impairs growth in human neurospheres and brain organoids","volume":"352","author":"Garcez","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jare.2023.01.006_b0880","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41586-019-1289-x","article-title":"Individual brain organoids reproducibly form cell diversity of the human cerebral cortex","volume":"570","author":"Velasco","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jare.2023.01.006_b0885","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature22047","article-title":"Cell diversity and network dynamics in photosensitive human brain organoids","volume":"545","author":"Quadrato","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jare.2023.01.006_b0890","doi-asserted-by":"crossref","first-page":"e0161969","DOI":"10.1371\/journal.pone.0161969","article-title":"Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes","volume":"11","author":"Raja","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2023.01.006_b0895","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","article-title":"Modeling amyloid beta and tau pathology in human cerebral organoids","volume":"23","author":"Gonzalez","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jare.2023.01.006_b0900","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","article-title":"APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2023.01.006_b0905","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jare.2023.01.006_b0910","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","article-title":"A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease","volume":"21","author":"Park","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2023.01.006_b0915","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41586-020-1962-0","article-title":"Cell stress in cortical organoids impairs molecular subtype specification","volume":"578","author":"Bhaduri","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jare.2023.01.006_b0920","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000707","article-title":"Robust production of uniform human cerebral organoids from pluripotent stem cells","volume":"3","author":"Sivitilli","year":"2020","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.jare.2023.01.006_b0925","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.stemcr.2020.06.001","article-title":"Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies","volume":"15","author":"Pomeshchik","year":"2020","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0930","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12015-016-9680-6","article-title":"Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications","volume":"13","author":"Yoshihara","year":"2017","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0935","doi-asserted-by":"crossref","first-page":"246","DOI":"10.18632\/aging.100653","article-title":"Aging in iPS cells","volume":"6","author":"Miller","year":"2014","journal-title":"Aging"},{"key":"10.1016\/j.jare.2023.01.006_b0940","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/emmm.201200215","article-title":"Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease","volume":"4","author":"Sanchez-Danes","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jare.2023.01.006_b0945","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","article-title":"Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure","volume":"165","author":"Qian","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jare.2023.01.006_b0950","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jare.2023.01.006_b0955","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1038\/s41598-019-53007-6","article-title":"Direct Conversion of Human Urine Cells to Neurons by Small Molecules","volume":"9","author":"Xu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2023.01.006_b0960","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1073\/pnas.1720273115","article-title":"Transdifferentiation of human adult peripheral blood T cells into neurons","volume":"115","author":"Tanabe","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2023.01.006_b0965","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","article-title":"Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects","volume":"17","author":"Mertens","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jare.2023.01.006_b0970","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-genet-120417-031534","article-title":"Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases","volume":"52","author":"Mertens","year":"2018","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.jare.2023.01.006_b0975","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth.1972","article-title":"Small molecules enable highly efficient neuronal conversion of human fibroblasts","volume":"9","author":"Ladewig","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jare.2023.01.006_b0980","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/ncomms3183","article-title":"Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons","volume":"4","author":"Liu","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2023.01.006_b0985","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.stem.2015.07.006","article-title":"Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules","volume":"17","author":"Hu","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jare.2023.01.006_b0990","doi-asserted-by":"crossref","DOI":"10.1242\/dev.166074","article-title":"Brain organoids: advances, applications and challenges","volume":"146","author":"Qian","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.jare.2023.01.006_b0995","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nprot.2017.152","article-title":"Generation of human brain region-specific organoids using a miniaturized spinning bioreactor","volume":"13","author":"Qian","year":"2018","journal-title":"Nat Protoc"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123223000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123223000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:58:26Z","timestamp":1761857906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123223000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":199,"alternative-id":["S2090123223000061"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2023.01.006","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2023.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}